Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Ong Corp 423.00 6.55
Hindalco 145.95 2.13
Axis Ban 416.30 3.57
Reliance 932.75 0.04
Tata Stl 451.20 0.77
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Kabra Drugs Limited
Kabra Drugs Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:524322NSE:NABloomberg:KD@INReuters:KABD.BO
Market Lot: 1Face Value: 10ISIN Demat: INE323K01017
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Business
Kabra Drugs (KABRADG) is engaged in the field of pharmaceutical formulations. It was incorporated as private limited company on Aug. 22, 1989 and converted into a public limited company on Apr. 01, 1992. The company is part of the Kabra group of companies, which has diverse business activities. Shyka Softtech and Kabra Construction are other group companies....   More..
Future Plans
One To One
Recent news
Latest News
Kabra Drugs standalone quarterly net plummets 58.68%   -IRIS 19-Aug-13
Previous

 


Brief Financials (in Rs. Mn.) 
Period ending (months)31-Dec-2012(9)31-Mar-2012 (12)31-Mar-2011 (12)
Net sales 60.4458.4857.30
Other Income0.000.000.34
Total Income60.4458.4857.64
Cost of goods sold56.8954.8751.99
OPBDIT3.553.615.65
PAT1.600.462.13
Gross Block---
Equity capital43.8943.8943.89
EPS (Rs.)-0.010.00
DPS (Rs.)---
BV (Rs.)---
P/E range (x)-700.00 - 900.00NA
Debt / Equity (x)---
Operating margin (% of OI) 5.9 6.2 9.8
Net margin (% of OI) 2.6 0.8 3.7
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
Not Available
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Wealth Tracker | Tax Corner | NRI Centre | E-mail | Search in myiris | Advertise
All rights reserved. IRIS Business Services Limited
Disclaimer